We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$1.5B
AUM Growth
+$79.1M
Cap. Flow
+$24.7M
Cap. Flow %
1.64%
Top 10 Hldgs %
31.43%
Holding
99
New
7
Increased
27
Reduced
26
Closed
7

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$14.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
INSP icon
Inspire Medical Systems
INSP
+$11.3M
4
DHR icon
Danaher
DHR
+$11.2M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.4M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$13.6M
2
TMO icon
Thermo Fisher Scientific
TMO
+$9.99M
3
ELV icon
Elevance Health
ELV
+$9.26M
4
BIIB icon
Biogen
BIIB
+$9M
5
RVNC
Revance Therapeutics, Inc.
RVNC
+$8.91M

Sector Composition

Rank Sector Weight
1 Healthcare 97.82%
2 Industrials 1.29%
3 Technology 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
51
DELISTED
Dynavax Technologies
DVAX
$10.7M 0.71%
750,000
– –
MGTX icon
52
MeiraGTx Holdings
MGTX
$1.21B
$10.5M 0.7%
450,000
– –
ALGN icon
53
Align Technology
ALGN
$12.5B
$9.93M 0.66%
+15,000
New +$9.64M
HCAT icon
54
Health Catalyst
HCAT
$127M
$9.73M 0.65%
240,000
– –
NVCR icon
55
NovoCure
NVCR
$2.02B
$9.61M 0.64%
120,387
+60,387
+101% +$6.06M
HRMY icon
56
Harmony Biosciences
HRMY
$2.27B
$9.53M 0.63%
220,000
+15,124
+7% +$603K
ONEM
57
DELISTED
1Life Healthcare
ONEM
$9.2M 0.61%
530,000
+110,000
+26% +$2.13M
SILK
58
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$8.66M 0.58%
200,000
+54,000
+37% +$2.7M
EXAS
59
DELISTED
Exact Sciences
EXAS
$8.57M 0.57%
110,000
-70,000
-39% -$6.18M
GKOS icon
60
Glaukos
GKOS
$10.7B
$8.02M 0.53%
175,000
+25,000
+17% +$1.15M
OSH
61
DELISTED
Oak Street Health, Inc.
OSH
$7.71M 0.51%
220,000
+115,000
+110% +$4.35M
CYTK icon
62
Cytokinetics
CYTK
$10.5B
$6.84M 0.45%
+150,000
New +$5.79M
SWAV
63
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$6.11M 0.41%
34,000
– –
SGMO
64
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.97M 0.4%
765,000
– –
EPIX
65
DELISTED
ESSA Pharma
EPIX
$5.93M 0.39%
420,000
-180,000
-30% -$2.01M
ISEE
66
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.75M 0.38%
350,000
– –
ACCD
67
DELISTED
Accolade Inc
ACCD
$5.52M 0.37%
210,000
-115,000
-35% -$3.77M
AERI
68
DELISTED
Aerie Pharmaceuticals
AERI
$5.38M 0.36%
750,000
– –
PHR icon
69
Phreesia
PHR
$769M
$5.24M 0.35%
123,465
– –
PGNY icon
70
Progyny
PGNY
$2.18B
$5.19M 0.35%
101,262
+21,262
+27% +$1.19M
STXS icon
71
Stereotaxis
STXS
$143M
$4.98M 0.33%
800,000
– –
SAGE
72
DELISTED
Sage Therapeutics
SAGE
$4.97M 0.33%
115,000
– –
ESPR
73
DELISTED
Esperion Therapeutics
ESPR
$4.96M 0.33%
1,000,000
+377,733
+61% +$3.02M
ALKS icon
74
Alkermes
ALKS
$8.29B
$4.9M 0.33%
210,000
– –
MGNX icon
75
MacroGenics
MGNX
$259M
$4.89M 0.33%
300,653
-244,507
-45% -$4.6M
1 2
3
4

Similar funds

ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return
AF
Ally Financial Detroit, Michigan $804M AUM 0.18% 1-Year Est. Return

Rhenman & Partners Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Rhenman & Partners Asset Management held 99 positions worth $1.5B, up 5.6% from $1.42B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rhenman & Partners Asset Management's Q4 2021 filing shows 7 new, 27 increased, 26 reduced and 7 closed positions. Its largest new stake was Inspire Medical Systems: 46,373 shares worth $10.7M. The largest sale was Abbott, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Industrials and Technology.

  • Rhenman & Partners Asset Management's largest Q4 2021 buy was Inspire Medical Systems: 46,373 shares worth $10.7M.
  • Rhenman & Partners Asset Management added most to Boston Scientific in Q4 2021, an estimated $14.3M increase.
  • Rhenman & Partners Asset Management's biggest Q4 2021 reduction was Abbott, cutting an estimated $13.6M.
  • Rhenman & Partners Asset Management fully exited Revance Therapeutics, Inc. in Q4 2021, selling an estimated $8.91M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 31% of its $1.5B portfolio in Q4 2021.
  • Rhenman & Partners Asset Management opened 7 new positions and closed 7 in Q4 2021.
  • Rhenman & Partners Asset Management's portfolio value rose 5.6% quarter-over-quarter to $1.5B.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.